Will have to wait for final words in scientific journal: CSIR...

New Delhi [India], November 25 (ANI): A day after Serum Institute of India (SII) Chief Executive Officer Adar...

Serum Institute of India CEO expresses delight at Covishield...

New Delhi [India], November 23 (ANI): Serum Institute of India (SII), CEO, Adar Poonawalla on Monday said that he is...

COVISHIELD completes enrolment of Phase III clinical trials...

New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research...

After Serum Institute tweet, Union Health Ministry says its...

New Delhi [India], September 29 (ANI): Following a tweet by the Serum Institute of India, the Union Health Ministry...

Serum Institute of India to produce additional 100 million...

Pune (Maharashtra) [India], September 29 (ANI): Serum Institute of India (SII) will produce up to an additional 100...

Serum Institute all set to begin phase 3 trials of Covid-19...

Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three...

DCGI gives nod to Serum Institute to restart phase 2,3 trials...

New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of...

Serum Institute to resume COVID-19 vaccine trials in India...

New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus...

DCGI directs Serum Institute to suspend any new recruitment...

New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered...

Serum Institute says will adhere to DCGI instructions after...

New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a...

DCGI sends show cause notice to Serum Institute for not...

New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice...

Oxford COVID-19 vaccine trials not paused in India, clarifies...

New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian...